South Korea · Delayed Price · Currency is KRW CellBion Statistics
Total Valuation
CellBion has a market cap or net worth of KRW 193.58 billion. The enterprise value is 156.27 billion.
| Market Cap | 193.58B |
| Enterprise Value | 156.27B |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CellBion has 12.91 million shares outstanding.
| Current Share Class | 12.91M |
| Shares Outstanding | 12.91M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 36.28% |
| Owned by Institutions (%) | n/a |
| Float | 8.22M |
Valuation Ratios
The trailing PE ratio is 24.98.
| PE Ratio | 24.98 |
| Forward PE | n/a |
| PS Ratio | 90.22 |
| PB Ratio | 5.36 |
| P/TBV Ratio | 5.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 20.17 |
| EV / Sales | 72.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 33.44, with a Debt / Equity ratio of 0.84.
| Current Ratio | 33.44 |
| Quick Ratio | 32.79 |
| Debt / Equity | 0.84 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.84 |
| Interest Coverage | -15.03 |
Financial Efficiency
Return on equity (ROE) is 24.79% and return on invested capital (ROIC) is -12.57%.
| Return on Equity (ROE) | 24.79% |
| Return on Assets (ROA) | -10.41% |
| Return on Invested Capital (ROIC) | -12.57% |
| Return on Capital Employed (ROCE) | -11.81% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 55 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 5.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.52% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -46.52% |
| 50-Day Moving Average | 15,081.00 |
| 200-Day Moving Average | 23,184.05 |
| Relative Strength Index (RSI) | 55.97 |
| Average Volume (20 Days) | 26,824 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellBion had revenue of KRW 2.15 billion and earned 7.75 billion in profits.
| Revenue | 2.15B |
| Gross Profit | -122.13M |
| Operating Income | -9.60B |
| Pretax Income | 7.75B |
| Net Income | 7.75B |
| EBITDA | -8.95B |
| EBIT | -9.60B |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 67.65 billion in cash and 30.34 billion in debt, with a net cash position of 37.31 billion or 2,891.36 per share.
| Cash & Cash Equivalents | 67.65B |
| Total Debt | 30.34B |
| Net Cash | 37.31B |
| Net Cash Per Share | 2,891.36 |
| Equity (Book Value) | 36.13B |
| Book Value Per Share | n/a |
| Working Capital | 67.48B |
Cash Flow
In the last 12 months, operating cash flow was -6.81 billion and capital expenditures -3.88 billion, giving a free cash flow of -10.69 billion.
| Operating Cash Flow | -6.81B |
| Capital Expenditures | -3.88B |
| Depreciation & Amortization | 646.41M |
| Net Borrowing | 24.23B |
| Free Cash Flow | -10.69B |
| FCF Per Share | -828.19 |
Margins
Gross margin is -5.69%, with operating and profit margins of -447.23% and 361.16%.
| Gross Margin | -5.69% |
| Operating Margin | -447.23% |
| Pretax Margin | 361.16% |
| Profit Margin | 361.16% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CellBion does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.00% |
| FCF Yield | -5.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CellBion has an Altman Z-Score of 3.94 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.94 |
| Piotroski F-Score | 2 |